These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preparation of neurotensin analogue-containing poly(dl-lactic acid) microspheres formed by oil-in-water solvent evaporation. Yamakawa I; Tsushima Y; Machida R; Watanabe S J Pharm Sci; 1992 Sep; 81(9):899-903. PubMed ID: 1432637 [TBL] [Abstract][Full Text] [Related]
4. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Okada H; Doken Y; Ogawa Y; Toguchi H Pharm Res; 1994 Aug; 11(8):1143-7. PubMed ID: 7971715 [TBL] [Abstract][Full Text] [Related]
5. In vivo characteristics of injectable poly(DL-lactic acid) microspheres for long-acting drug delivery. Kobayashi D; Tsubuku S; Yamanaka H; Asano M; Miyajima M; Yoshida M Drug Dev Ind Pharm; 1998 Sep; 24(9):819-25. PubMed ID: 9876532 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of high-content aripiprazole-loaded core-shell structure microsphere for long-release injectable formulation. Hiraoka S; Uchida S; Namiki N Chem Pharm Bull (Tokyo); 2014; 62(7):654-60. PubMed ID: 24990503 [TBL] [Abstract][Full Text] [Related]
7. Controlled release of 3',5'-diester prodrugs of 5-fluoro-2'-deoxyuridine from poly-L-lactic acid microspheres. Seki T; Kawaguchi T; Endoh H; Ishikawa K; Juni K; Nakano M J Pharm Sci; 1990 Nov; 79(11):985-7. PubMed ID: 2149864 [TBL] [Abstract][Full Text] [Related]
8. Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres. Urata T; Arimori K; Nakano H J Control Release; 1999 Mar; 58(2):133-41. PubMed ID: 10053186 [TBL] [Abstract][Full Text] [Related]
9. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies. Bodmeier R; McGinity JW J Microencapsul; 1988; 5(4):325-30. PubMed ID: 3236152 [TBL] [Abstract][Full Text] [Related]
10. 25-Hydroxyvitamin D(3)-loaded PLA microspheres: in vitro characterization and application in diabetic periodontitis models. Li H; Wang Q; Xiao Y; Bao C; Li W AAPS PharmSciTech; 2013 Jun; 14(2):880-9. PubMed ID: 23653087 [TBL] [Abstract][Full Text] [Related]
11. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release. Kim HK; Park TG J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894 [TBL] [Abstract][Full Text] [Related]
12. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics. Jalil R; Nixon JR J Microencapsul; 1990; 7(3):357-74. PubMed ID: 2384838 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of polylactic acid microspheres containing bovine insulin by a w/o/w emulsion solvent evaporation method. Uchida T; Nagareya N; Sakakibara S; Konishi Y; Nakai A; Nishikata M; Matsuyama K; Yoshida K Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1539-43. PubMed ID: 9332006 [TBL] [Abstract][Full Text] [Related]
14. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method. Uchida T; Yoshida K; Goto S J Microencapsul; 1996; 13(2):219-28. PubMed ID: 8999126 [TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474 [TBL] [Abstract][Full Text] [Related]
17. Controlled release of thyrotropin releasing hormone from microspheres: evaluation of release profiles and pharmacokinetics after subcutaneous administration. Heya T; Mikura Y; Nagai A; Miura Y; Futo T; Tomida Y; Shimizu H; Toguchi H J Pharm Sci; 1994 Jun; 83(6):798-801. PubMed ID: 9120809 [TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery. Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548 [TBL] [Abstract][Full Text] [Related]
19. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin. Uchida T; Yoshida K; Ninomiya A; Goto S Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1569-73. PubMed ID: 7586084 [TBL] [Abstract][Full Text] [Related]